Skip to main content
. 2021 Sep 28;9:711616. doi: 10.3389/fpubh.2021.711616

Table 10.

The defect in testosterone in COVID 19.

The Defect Reference The sample size The affected patients Incidence
Okçelik, Sezgin. “COVID-19 pneumonia causes lower testosterone levels.” Andrologia, e13909. 19 Nov. 2020, doi: 10.1111/and.13909 24 9 patients have low testosterone 37.5%
7 patients have high LH About 29%
Decrease Testosterone [T] levelIncrease luteinizing hormone LHT: LH may decrease in COVID 19 patient Wang, Zhengpin, and Xiaojiang Xu. “scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells.” Cells vol. 9,4 920. 9 Apr. 2020, doi: 10.3390/cells9040 16,632 cells ACE2 expression finding in testicular cells with variations ACE2 represented as :1.4% in spermatogonia4.25% in Leydig and Sertoli cells
Yang, Ming et al. “Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications.” European urology focus vol. 6,5 (2020): 1124-1129. doi: 10.1016/j.euf.2020.05.009 12 11 About 91 % have testicular injury